Skip to main content
Travis Hollmann, MD, Pathology, New York, NY

Travis Jason Hollmann MD

Dermatopathology, Anatomic Pathology, Clinical Pathology


Assistant Professor

Join to View Full Profile
  • 1275 York AvenueMemorial Hospital/ Dept. Of PathologyNew York, NY 10065

  • Phone+1 212-639-8134

Dr. Hollmann is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Beth Israel Deaconess Medical Center/Harvard Medical School
    Beth Israel Deaconess Medical Center/Harvard Medical SchoolFellowship, Dermatopathology, 2008 - 2009
  • Mass General Brigham/Brigham and Women's Hospital
    Mass General Brigham/Brigham and Women's HospitalResidency, Pathology-Anatomic and Clinical, 2005 - 2008
  • McGovern Medical School at UTHealth
    McGovern Medical School at UTHealthClass of 2005

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2012 - 2026
  • RI State Medical License
    RI State Medical License 2023 - 2026
  • CA State Medical License
    CA State Medical License 2023 - 2025
  • NJ State Medical License
    NJ State Medical License 2021 - 2025
  • MA State Medical License
    MA State Medical License 2009 - 2012
  • PA State Medical License
    PA State Medical License 2012 - 2012
  • Pathology - Anatomic
    American Board of Pathology Pathology - Anatomic
  • Dermatopathology
    American Board of Pathology Dermatopathology

Publications & Presentations

PubMed

Journal Articles

  • Massively Parallel Sequencing Analysis of Benign Melanocytic Nevi  
    Allan C Halpern, Travis J Hollmann, Klaus J Busam, Histopathology
  • Microenvironment-Derived Factors Driving Metastatic Plasticity in Melanoma  
    Liang Lu, Travis Hollmann, Nature

Abstracts/Posters

  • Final Results of a Phase II Biomarker-Driven Study of Ruxolitinib in Relapsed and Refractory T-Cell Lymphoma
    Travis Hollmann, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Press Mentions

  • Molecular and Microenvironmental Landscapes of Human Papillomavirus-Independent Invasive Squamous Cell Carcinoma of the Vulva
    Molecular and Microenvironmental Landscapes of Human Papillomavirus-Independent Invasive Squamous Cell Carcinoma of the VulvaFebruary 19th, 2025
  • Treatment of Metastatic Extramammary Paget Disease with Combination Ipilimumab and Nivolumab: A Case Report
    Treatment of Metastatic Extramammary Paget Disease with Combination Ipilimumab and Nivolumab: A Case ReportMarch 12th, 2021
  • For Advanced Pancreatic Cancer, Combining Immunotherapies with Chemotherapy Shows Early Promise in Reducing Tumor Size
    For Advanced Pancreatic Cancer, Combining Immunotherapies with Chemotherapy Shows Early Promise in Reducing Tumor SizeMarch 26th, 2019

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: